Pr 2263350 initial emdr submission.A follow up emdr will be submitted if additional information becomes available.Patient problem code: (b)(4).Device problem code: (b)(4).No additional information was provided by pfizer.Primevigilance did reach out to obtain with no success.Should additional information be available in the future, the complaint will be re-opened and investigated.All complaints are reviewed during monthly quality/safety meetings.In addition, complaints are trended at monthly quality data analyst meetings and quarterly plant management review meetings.
|
Material no.: unknown batch no.: unknown it was reported that the patient experienced nausea, body aches, night sweats, headache, and tiredness involving chloraprep."re: adverse event involving chloraprep (allergy)" nausea, body aches, night sweats, headache, and tiredness.
|